Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Event category

Content archived on 2022-07-06

Article available in the following languages:

EN

cGMP Training for Biotechnology and Pharmaceutical Industries in Europe - U.S FDA Perspective

Are you working in the biotechnology or pharmaceutical industry in Europe and interested in staying current with the changing world of cGMPs, specifically from the perspective of the United States Food and Drug Administration?

22 April 2004 - 23 April 2004
United Kingdom
Two-day training seminar in London, UK: April 22 and 23, 2004,http://www.spi.pt/seminar
cGMP SEMINAR TOPICS:,- Introduction to cGMPs and the FDA ,- Raw Materials, Laboratory and Process Control ,- Quality Concepts; Organization of the Quality Unit ,- Labeling & Identification ,- GLPs ,- Cleaning; Cross-contamination Prevention ,- cGMP Documentation; Validation Issues ,- Inspections & Investigations ,- Gowning Procedures ,- International cGMPs ,- Standard Operating Procedures and Batch Records ,- New trends in cGMP compliance
WHO SHOULD ATTEND ?,- Those responsible for achieving and maintaining a state of compliance with international cGMP requirements related to the biotechnology and pharmaceutical industries, specifically the European Agency for the Evaluation of Medicinal Products (EMEA) and the Food and Drug Administration (FDA).
- Personnel associated with supply companies.
- Professionals responsible for Compliance, Regulatory Affairs, Project Planning, Technology Transfer, Quality Assurance, Quality Control, Research & Development, and Manufacturing
,
My booklet 0 0